What are the business & financing risks associated with the acquisition of Genentech? Is this a good time to do the deal (and why)?
Do you believe that the deal and bond issuance will have an impact on Roche’s credit rating (and why)? What would be your recommendation for the coupon rate (or spreads) for the Roche 5-year, 10-y
r and 30-year USS bonds’? What would be your recommendation for the coupon on the 7-year Euro bond?